By GEORGE BEAUREGARD During my years in a bustling metropolitan primary care practice from 1992 to 2010, I recall only a handful of patients under 50 who developed cancer. Not surprisingly, these were mostly cases of Hodgkin’s and Non-Hodgkin’s lymphomas, myeloma, skin, and breast cancer. Fortunately, those few patients were wearing the mantle of cancer…
In 2017, the Republicans who controlled Congress tried mightily to slash federal spending on Medicaid, the government-funded health program covering low-income families and individuals. California, like other states, depends heavily on federal dollars to provide care for its poorest residents. Analyses at the time showed the GOP’s proposals would cut Medicaid funds flowing from Washington…
By MATTHEW HOLT So I am back dealing with Labcorp & Blue Shield of California over the mysterious $34 copay. If you want to catch up go here Over the weekend Labcorp sent me a final due notice on my bill…. the one that they couldn’t tell me about without asking for all the information…
This issue brief describes the hardship exception for individuals living in counties with high unemployment, and using the most recent available county-level unemployment data, estimates the number of counties that could meet the criteria for this exception and the number of expansion enrollees living in those counties who could be exempt from work requirements.
Wisp is now offering at-home testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium. The post Wisp Unveils Diagnostics Arm appeared first on MedCity News.
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023. The post Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023 appeared first on MedCity News.
That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…
OHA will launch a public website to showcase the key measures used to track progress on the strategic plan
Contrary to fears of clinician replacement, AI’s near-term potential lies in complementing human expertise, particularly by handling behind-the-scenes tasks that improve efficiency and precision. Here’s where we might see the most impact. The post The Near-Term Future of AI in Health Care appeared first on MedCity News.
Government documents viewed by KFF Health News show a drop in patients receiving care this year at the National Institutes of Health’s renowned research hospital, a 200-bed facility at NIH headquarters in Maryland. We previously reported a decrease in the number of patients being treated at the NIH Clinical Center from February through April. Since then,…